Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000950170-25-020936·Whitehawk Therapeutics, Inc.
Schedule 13G ownership disclosure
Whitehawk Therapeutics, Inc.
Common stock, $0.0001 par value per share · CUSIP: 00032Q104
Event date: 2024-12-31
- Filing-level shares
- 2,313,702
- Percent of class
- 9.37%
- QVT Financial LP
Shares: 2,313,702 · Class: 9.37%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-020936
- Form type
- SCHEDULE 13G
- Filer
- Whitehawk Therapeutics, Inc.
- CIK
- CIK 1422142
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership